Tazloc Am Tablet is a widely prescribed dual-combination antihypertensive medication used to effectively treat high blood pressure (hypertension) in adult patients. This fixed-dose combination brings together two powerful agents that work synergistically to lower blood pressure, protect the heart, and reduce the risk of cardiovascular events such as stroke, heart attack, and kidney failure.

• Amlodipine 5 MG is a calcium channel blocker (CCB) that relaxes the smooth muscles in the blood vessel walls, causing them to dilate. This improves blood flow and reduces blood pressure.

• Telmisartan 40 MG is an angiotensin II receptor blocker (ARB) that prevents the action of angiotensin II — a substance that narrows blood vessels. By blocking it, Telmisartan allows blood vessels to stay relaxed and open.

This dual therapy is ideal for patients who do not achieve adequate blood pressure control with monotherapy. It offers a convenient once-daily dosage that enhances compliance, and it is well-suited for long-term use under medical supervision.

By addressing two different mechanisms in blood pressure regulation, Amlodipine + Telmisartan offers faster and more sustained blood pressure control than either agent alone. It is also associated with fewer side effects compared to higher doses of single drugs, improving patient tolerance and long-term outcomes.